Microstructural abnormalities in multiple system atrophy as revealed by conventional and rotating frame relaxation MRI parameters.

Rotating frame relaxation (RFR) techniques provide robust and sensitive quantitative MRI (qMRI) metrics able to detect subtle alterations of brain tissue integrity in multiple neurological disorders. We performed a cross-sectional qMRI study in 16 patients with Multiple System Atrophy (MSA) and 14 age- and sex-matched healthy controls. The MRI protocol included the acquisition of RFR metrics, namely adiabatic T1ρ and T2ρ relaxation time constants, along with the acquisition of conventional relaxation metrics, namely R1 and R2*, and a semi-quantitative metric describing magnetization transfer (MT). Between-group comparisons of voxel-based and region-based outcomes were obtained both with and without accounting for the effect of atrophy. Significant brain atrophy was observed in the MSA patients in the white matter and grey matter of the cerebellum, and frontal white matter. On the other hand, group differences of virtually all relaxation metrics were observed for both voxel-wise and ROI analyses in many brain areas. These differences were reduced in spatial extent and/or effect size when the atrophy effect was accounted for. However, T1ρ values remained significantly longer in patients' ROIs encompassing both cerebellar grey matter and white matter, while MT, and R1 values were smaller. Cerebellar gray matter ROIs of patients also exhibited longer T2ρ and smaller R2*. Other voxel-wise group differences were still present after atrophy correction in several clusters, including among others, longer T1ρ in patients' putamen, and longer T1ρ and T2ρ and smaller MT in the patients' pons. Altogether, our findings suggest multiple processes of tissue integrity loss during the course of neurodegeneration that go beyond macrostructural alterations. We conclude that adiabatic T1ρ and T2ρ are valuable MRI metrics that expand the set of multi-parametric qMRI available to characterize the brain of MSA, providing additional and specific information on the brain tissue alterations occurring in this disease.